Fresenius faces more than 5,500 NaturaLyte, GranuFlo lawsuits
Fresenius Medical Care, the world’s largest provider of dialysis services and products, is facing more than 5,500 lawsuits alleging the company’s dialysis concentrates caused patients to suffer sudden cardiac arrest.
New meta-analysis raises serious questions about SSRI use during pregnancy
There is not enough research to provide a clear guidance on the risks or benefits of antidepressant use during pregnancy, however there are serious concerns regarding the drugs’ affects on newborns that should be addressed, a new meta-analysis has found.
European advisors recommend approval of new combination type 2 diabetes treatment
An advisory panel for European drug regulators is recommending approval for a new type 2 diabetes drug combining the long-acting insulin degludec with Victoza (liraglutide). The favorable recommendation of Novo Nordisk’s drug Xultophy, previously known as IDegLira, was based on
Risperidone side effects send patients to the emergency room
Adverse effects of antipsychotic medications such as Risperdal (risperidone) send more than 20,000 people in the United States to the emergency room each year, prompting the American Psychiatric Association to issue an advisory to clinicians to carefully evaluate patients before
Acetaminophen as effective as placebo in treating lower back pain
The commonly used painkiller acetaminophen, the same drug in over-the-counter Tylenol, doesn’t relieve lower-back pain any better than a placebo, according to a new study published in the journal The Lancet.
FDA approves oxycodone combination drug that resists abuse
A powerful combination opioid painkiller whose euphoric effects can be rendered inactive if the drug is tampered with has been approved by the Food and Drug Administration (FDA). The drug’s formulation aligns with the agency’s commitment to combat the misuse
Teen’s death prompts FDA warning for consumers to avoid pure caffeine powder
Logan Stiner was just days away from his high school graduation when he died after consuming a lethal dose of powdered caffeine. The teen’s death prompted a Food and Drug Administration (FDA) investigation resulting in the agency issuing a warning
McNeil loses appeal on $10 million Children’s Motrin judgment
Johnson & Johnson subsidiary McNeil-PPC failed to convince the Pennsylvania Superior Court to overturn a $10 million verdict alleging the company’s Children’s Motrin caused a girl to develop a life threatening condition that burned her skin and caused her to
Pharmacy group wants black box warning added to antibiotic Levaquin
A University of South Carolina pharmacy group is petitioning the Food and Drug Administration (FDA) to put the strongest warning possible on Johnson & Johnson’s antibiotic Levaquin alerting consumers about the potential for cellular damage that could lead to serious diseases.